These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37382435)

  • 41. Expression of CD26 (dipeptidyl peptidase IV) on memory and naive T lymphocytes.
    Ulmer AJ; Mattern T; Flad HD
    Scand J Immunol; 1992 May; 35(5):551-9. PubMed ID: 1374571
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incorporation of a hinge domain improves the expansion of chimeric antigen receptor T cells.
    Qin L; Lai Y; Zhao R; Wei X; Weng J; Lai P; Li B; Lin S; Wang S; Wu Q; Liang Q; Li Y; Zhang X; Wu Y; Liu P; Yao Y; Pei D; Du X; Li P
    J Hematol Oncol; 2017 Mar; 10(1):68. PubMed ID: 28288656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rewiring mitochondrial metabolism to counteract exhaustion of CAR-T cells.
    Huang Y; Si X; Shao M; Teng X; Xiao G; Huang H
    J Hematol Oncol; 2022 Mar; 15(1):38. PubMed ID: 35346311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allogeneic chimeric antigen receptor-T cells with CRISPR-disrupted programmed death-1 checkpoint exhibit enhanced functional fitness.
    Lau E; Kwong G; Fowler TW; Sun BC; Donohoue PD; Davis RT; Bryan M; McCawley S; Clarke SC; Williams C; Banh L; Irby M; Edwards L; Storlie M; Kohrs B; Lilley GWJ; Smith SC; Gradia S; Fuller CK; Skoble J; Garner E; van Overbeek M; Kanner SB
    Cytotherapy; 2023 Jul; 25(7):750-762. PubMed ID: 37086241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of
    Shouval R; Alarcon Tomas A; Fein JA; Flynn JR; Markovits E; Mayer S; Olaide Afuye A; Alperovich A; Anagnostou T; Besser MJ; Batlevi CL; Dahi PB; Devlin SM; Fingrut WB; Giralt SA; Lin RJ; Markel G; Salles G; Sauter CS; Scordo M; Shah GL; Shah N; Scherz-Shouval R; van den Brink M; Perales MA; Palomba ML
    J Clin Oncol; 2022 Feb; 40(4):369-381. PubMed ID: 34860572
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD19 Chimeric Antigen Receptor T Cells From Patients With Chronic Lymphocytic Leukemia Display an Elevated IFN-γ Production Profile.
    Magalhaes I; Kalland I; Kochenderfer JN; Österborg A; Uhlin M; Mattsson J
    J Immunother; 2018; 41(2):73-83. PubMed ID: 29315094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD26-mediated co-stimulation in human CD8(+) T cells provokes effector function via pro-inflammatory cytokine production.
    Hatano R; Ohnuma K; Yamamoto J; Dang NH; Morimoto C
    Immunology; 2013 Feb; 138(2):165-72. PubMed ID: 23113658
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myeloid cells in peripheral blood mononuclear cell concentrates inhibit the expansion of chimeric antigen receptor T cells.
    Stroncek DF; Ren J; Lee DW; Tran M; Frodigh SE; Sabatino M; Khuu H; Merchant MS; Mackall CL
    Cytotherapy; 2016 Jul; 18(7):893-901. PubMed ID: 27210719
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antitumor Potency of an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, Lisocabtagene Maraleucel in Combination With Ibrutinib or Acalabrutinib.
    Qin JS; Johnstone TG; Baturevych A; Hause RJ; Ragan SP; Clouser CR; Jones JC; Ponce R; Krejsa CM; Salmon RA; Ports MO
    J Immunother; 2020 May; 43(4):107-120. PubMed ID: 31899702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2.
    Gargett T; Brown MP
    Cytotherapy; 2015 Apr; 17(4):487-95. PubMed ID: 25573334
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.
    Fraietta JA; Lacey SF; Orlando EJ; Pruteanu-Malinici I; Gohil M; Lundh S; Boesteanu AC; Wang Y; O'Connor RS; Hwang WT; Pequignot E; Ambrose DE; Zhang C; Wilcox N; Bedoya F; Dorfmeier C; Chen F; Tian L; Parakandi H; Gupta M; Young RM; Johnson FB; Kulikovskaya I; Liu L; Xu J; Kassim SH; Davis MM; Levine BL; Frey NV; Siegel DL; Huang AC; Wherry EJ; Bitter H; Brogdon JL; Porter DL; June CH; Melenhorst JJ
    Nat Med; 2018 May; 24(5):563-571. PubMed ID: 29713085
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model.
    Shibao S; Minami N; Koike N; Fukui N; Yoshida K; Saya H; Sampetrean O
    Neuro Oncol; 2018 Feb; 20(3):343-354. PubMed ID: 29016888
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glycolytic reprogramming in macrophages and MSCs during inflammation.
    Li X; Shen H; Zhang M; Teissier V; Huang EE; Gao Q; Tsubosaka M; Toya M; Kushioka J; Maduka CV; Contag CH; Chow SK; Zhang N; Goodman SB
    Front Immunol; 2023; 14():1199751. PubMed ID: 37675119
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion.
    Kaartinen T; Luostarinen A; Maliniemi P; Keto J; Arvas M; Belt H; Koponen J; Mäkinen PI; Loskog A; Mustjoki S; Porkka K; Ylä-Herttuala S; Korhonen M
    Cytotherapy; 2017 Jun; 19(6):689-702. PubMed ID: 28411126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of CD26/dipeptidyl peptidase IV in human T cell activation and function.
    Ohnuma K; Takahashi N; Yamochi T; Hosono O; Dang NH; Morimoto C
    Front Biosci; 2008 Jan; 13():2299-310. PubMed ID: 17981712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD26 (dipeptidyl-peptidase IV)-dependent recruitment of T cells in a rat asthma model.
    Kruschinski C; Skripuletz T; Bedoui S; Tschernig T; Pabst R; Nassenstein C; Braun A; von Hörsten S
    Clin Exp Immunol; 2005 Jan; 139(1):17-24. PubMed ID: 15606609
    [TBL] [Abstract][Full Text] [Related]  

  • 57. On the role of CD26 in CD4 memory T cells.
    Cordero OJ; Yang CP; Bell EB
    Immunobiology; 2007; 212(2):85-94. PubMed ID: 17336829
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets.
    Willheim M; Ebner C; Baier K; Kern W; Schrattbauer K; Thien R; Kraft D; Breiteneder H; Reinisch W; Scheiner O
    J Allergy Clin Immunol; 1997 Sep; 100(3):348-55. PubMed ID: 9314347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations.
    Ruiz P; Zacharievich N; Shenkin M
    Clin Diagn Lab Immunol; 1998 May; 5(3):362-8. PubMed ID: 9605992
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Time-course effect of high-glucose-induced reactive oxygen species on mitochondrial biogenesis and function in human renal mesangial cells.
    Al-Kafaji G; Sabry MA; Skrypnyk C
    Cell Biol Int; 2016 Jan; 40(1):36-48. PubMed ID: 26251331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.